White Paper
Nov 28, 2025
Siponimod Hemifumarate API - Technical Profile & Offerings
Oct 24, 2025
Palbociclib API - Technical Profile & Offerings
Sep 25, 2025
Teach Sheet on LCZ696(Sacubitril Valsartan)API
Aug 28, 2025
Dabigatran – Ready to fill Pellets
Aug 4, 2025
Carfilzomib: API Technical Profile & Offerings
Jul 15, 2025
Apremilast API: Comprehensive Technical Data Sheet and Offerings
Jun 16, 2025
New Product Alert – Ruxolitinib Phosphate
May 26, 2025
Product Alert - Rimegepant
May 5, 2025
Product Alert – Mavacamten
Apr 24, 2025
Product Alert - Ripretinib
Mar 4, 2025
Product Alert - Lumateperone Tosylate
Feb 12, 2025
New Product Alert - Ribociclib
Jan 10, 2025
New Product Alert - Ruxolitinib & Salts
Dec 18, 2024
Tech Sheet On Nilotinib Hydrochloride
Oct 18, 2024
Tech Sheet – Mirabegron API
Sep 25, 2024
Tech sheet – Apremilast
Aug 4, 2024
Addressing the presence of mutagenic Azido impurities in Sartan APIs
May 31, 2024
Product Alert - Relugolix API
May 31, 2024
Tech Sheet on Enzalutamide Premix
May 31, 2024
Product Alert – Mirogabalin Besylate
Apr 22, 2024
Product Alert – Vonoprazan Fumarate
Feb 21, 2024
Tech Sheet - Cabozantinib (S)-malate API
Dec 7, 2023
Product Alert – Deucravacitinib API
Dec 4, 2023
Substantially Pure Carfilzomib Amorphous for Generic Launch
Nov 6, 2023
Product Alert – Mavacamten API
Jul 21, 2023
White Paper on Sugammadex API
Jul 21, 2023
Tech Sheet on Pregabalin API
Mar 20, 2023
Product Alert – Niraparib API
Mar 13, 2023
Product Alert – Tucatinib API
Mar 6, 2023
Product Alert – Pazopanib API
Jan 20, 2023
Tech Sheet on Midostaurin API
Jan 9, 2023
Tech Sheet on Tofacitinib Citrate
Nov 4, 2022
Tech Sheet on Dutasteride
Oct 14, 2022
Tech Sheet on Linagliptin
Oct 12, 2022
Tech Sheet on Voriconazole
Aug 3, 2022
Co-Crystal and Customized Particle Size for Early Launch Opportunity of Siponimod API
Jul 29, 2022
New Product Alert – Lumateperone Tosylate API
Jun 15, 2022
Tech sheet: Dr. Reddy's Bempedoic Acid API Offerings
Apr 4, 2022
Tech sheet: Dr. Reddy's Olaparib API Offerings
Mar 30, 2022
Tech sheet: Dr. Reddy's Enzalutamide API Offerings
Feb 22, 2022
Tech Sheet - Dr. Reddy’s Eribulin Mesylate API offerings
Feb 9, 2022
Tech Sheet – Dr. Reddy’s Fexofenadine API offerings
Feb 4, 2022
Tech Sheet - Dr. Reddy’s Azacitidine API offerings
Feb 4, 2022
Tech Sheet - Dr. Reddy’s Ramipril API offerings
Dec 17, 2021
Tech Sheet - Dr. Reddy’s Gemcitabine API offerings
Dec 2, 2021
Tech Sheet: Dr. Reddy’s Abiraterone Acetate API offerings
Oct 8, 2021
White Paper: Redyx: Remdesivir formulation developed at Dr. Reddy’s under the license from Gilead
Aug 17, 2021
Whitepaper : Dr.Reddy's 2 DG- A promising treatment in hospitalized COVID-19 patients
Aug 17, 2021
Techsheet: Dr.Reddy's Lenvatinib API offerings
Jun 18, 2021
ROXADUSTAT - a multipronged development strategy
May 19, 2021
Dr.Reddy's Apremilast API and finished formulation offerings.
May 3, 2021
Dr. Reddy’s Fosaprepitant API offerings
Apr 15, 2021
Apixaban API – ready-to-compress granules and finished dosage forms
Apr 6, 2021
Apalutamide API – an attractive NCE-1 opportunity for generic pharma companies
Apr 6, 2021
Colloidal Iron Complex Formulations – Understanding and Developing the Process
Feb 9, 2021
Rivaroxaban from Dr.Reddy’s: Full basket offerings of API and Finished formulations
Jan 22, 2021
Dr. Reddy's Mirabegron API offering in both alpha and amorphous form
Jan 13, 2021
Palbociclib – how a novel process development approach provides IP advantages
Nov 25, 2020
Dr. Reddy's Elagolix API offering leverages a well rounded Quality by Design approach
Jul 20, 2020
Sacubitril/Valsartan (LCZ696) – Bringing yet another advantage through innovative API offerings
Jul 10, 2020
Dr. Reddy’s Flow Chemistry experts share their perspectives in panel discussion of Chemistry Today
May 20, 2020
A closer look on how Dr. Reddy's met the stringent regulatory requirement of genotoxic impurities in Ranolazine
May 7, 2020
Famotidine and Nizatidine APIs: NDMA controlled, customized particle distribution, supply chain security
Oct 17, 2019
Meeting the New Regulatory Requirements in Sartan API Production
Articles
Jul 25, 2025
Development of Niche Products at Dr. Reddys API
Apr 2, 2025
Harnessing India's New Drug Development Capabilities for Global Impact
Mar 11, 2025
The Impact of Global Regulations on the Active Pharmaceutical Ingredient Industry
Mar 3, 2025
The Importance of Supply Chain Management and Dr. Reddy’s Excellence
Feb 10, 2025
Current Landscape of Cancer Treatment in India and Dr. Reddy's Role in Enhancing Care
Jan 12, 2025
Global Development Strategy for Generic Formulations and APIs
Jan 6, 2025
APIs for Emerging Markets: Opportunities and Challenges
Dec 15, 2024
Formulation Strategies and Pharmaceutical Analysis for Anti-diabetic APIs
Dec 2, 2024
API Quality Control Technologies & Strategies: Current Advancements for Benefiting Pharma Companies
Oct 9, 2024
A year of growth & Sustainability
Aug 30, 2024
Understanding Nitrosamines and GTI Issues in APIs: A Comprehensive Overview with Dr. Reddy's Perspective
Aug 28, 2024
Innovative Approaches to API Production in 2024: Shaping the Future of Pharma Companies
Jul 30, 2024
Continuous Manufacturing Process and Its Impact on Pharma Manufacturing
Jun 28, 2024
A Comparative Study on Naproxen Formulations
Jun 18, 2024
An effective strategy for the development of docetaxel
May 22, 2024
Preformulation Studies for Generic Omeprazole
May 15, 2024
A comparative study on enzalutamide Formulations
Apr 30, 2024
Navigating the Heart of Pharmaceuticals: An In-Depth Exploration of Active Pharmaceutical Ingredient Manufacturing for Essential Medicines
Apr 1, 2024
Presence of Organic Impurities in active pharmaceutical ingredients: An Overview
Mar 30, 2024
Strategies and Technologies for Enhancing Cost-Effectiveness in Active Pharmaceutical Ingredient (API) Production
Mar 29, 2024
Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs)
Feb 29, 2024
Ensuring Drug Safety: Comprehensive Analysis of Active Pharmaceutical Ingredient Lists
Feb 28, 2024
Unravelling the Science: Pharmaceutical Compositions and Process of Levetiracetam API
Nov 16, 2023
Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Refractory Chronic Lymphocytic Leukemia
Aug 10, 2023
Demonstrating Equivalence of Generic Glatiramer Acetate: Ensuring Quality and Safety
May 25, 2023
Streamlining the Process: Preparing a Pharmaceutical Composition of Fosaprepitant API
Dec 30, 2022
Steps taken by Dr. Reddy's Laboratories in controlling the environmental risks and safety management in the manufacturing of APIs
Dec 7, 2022
Meeting the New Regulatory Requirements and Controlling of Nitrosamine Impurities in Sartan API Production
Sep 14, 2022
Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients
Sep 13, 2022
Reshaping the Pharmaceutical API Industry with Digital Transformation
Aug 2, 2022
7 Ways how Active Pharmaceutical Ingredients (APIs) Enable Indian Pharmaceutical Companies to Grow
Aug 2, 2022
How is the Indian Pharmaceutical industry gearing up for 2022-2023?
Apr 14, 2022
Impact of COVID-19 on Indian HPAPI industry
Apr 14, 2022
The synthesis of active pharmaceutical ingredients (APIs) using continuous flow chemistry
Sep 14, 2021
ANVISA Certification of GMP Pharmaceutical Ingredients for 61 of Dr Reddy’s APIs
Jul 7, 2021
Managing the Product Life Cycle: Naproxen API and formulations
May 27, 2021
Understanding Active Pharmaceutical Ingredients: CPHI talk by Dr. Ramani Susarla
Mar 31, 2021
EMA Nitrosamine Guidance – Deadline March 31, 2021
Nov 26, 2020
Patient centricity and supply chain security in 2021 - Rajesh Sadanandan speaks on CPhI Pharma Trends 2021
Nov 19, 2020
Dr. Reddy's research publication on simultaneous automated image analysis and Raman spectroscopy of powders at an individual particle level
Sep 14, 2020
A Paradigm Shift that Is Here to Stay - Sauri Gudlavalleti speaks to CME Manager on COVID-19 response
Sep 7, 2020
A Year of Challenge and Opportunity - Deepak Sapra, Global Head of PSAI speaks to The Medicine Maker
Sep 2, 2020
COVID-19 and What’s Next for API Sourcing?
Aug 25, 2020
Indian healthcare reform offers thriving pharmaceutical market opportunities: Interview with Deepak Sapra
Jun 1, 2020
Dr. Reddy’s is improving supply chain performance for Pregabalin API through large manufacturing capacity and backward integration
Dec 1, 2019
Enhancing Supply Chain Security for Levetiracetam API
News
Updates
2020 - December
Dapagliflozin Propane Diol
Brazil DMF
2020 - December
Abiraterone Acetate
Brazil DMF
2020 - December
Sugammadex Sodium
China DMF
2020 - December
Lurasidone HCl
China DMF
2020 - December
Raloxifene HCl
China DMF
2020 - December
Apremilast (Form-B)
China DMF
2020 - December
Atorvastatin Calcium [Form-1] [ATN]
Korea DMF
2020 - December
Rabeprazole Sodium (Amorphous)
CEP Submitted
2020 - December
Pregabalin
Japan DMF
2020 - December
Famotidine
Japan DMF
2020 - December
Lenalidomide
USDMF
2020 - December
Clopidogrel Bisulfate
USDMF
2020 - December
Roxadustat
USDMF
2020 - December
Elagolix
USDMF
2020 - December
Atorvastatin Calcium Trihydrate [Form-1] [ATN]
Brazil DMF
2020 - December
Montelukast Sodium USP
Brazil DMF
2020 - December
Pregabalin
Brazil DMF
2020 - December
Capecitabine
Brazil DMF
2020 - November
Sitagliptin Phosphate (Anhydrous)
China DMF
2020 - November
Dutasteride (Form-II)
Canada DMF
2020 - November
Rabeprazole Sodium Hydrate (form-Y) RBL process
CEP Submitted
2020 - November
Clopidogrel Bisulphate [Form-I] (CIP)
Brazil DMF
2020 - October
Divalproex Sodium
Brazil DMF
2020 - October
Rivaroxaban
Brazil DMF
2020 - October
Mirabegron Amorphous
Brazil DMF
2020 - September
Losartan K
Brazil DMF
2020 - September
Ondansetron HCl
China DMF
2020 - September
Canagliflozin Hemihydrate
China DMF
2020 - September
Raloxifene HCl
Korea DMF
2020 - September
Escitalopram Oxalate
Korea DMF
2020 - September
Ticagrelor
CEP Submitted
2020 - September
Fexofenadine HCl ( form X)
Japan DMF
2020 - September
Midostaurin
USDMF
2020 - August
Keterolac Tromethamine
Brazil DMF
2020 - August
Ondansetron Hydrochloride
Brazil DMF
2020 - August
Sitagliptin Phosphate Anhydrous
Brazil DMF
2020 - August
Naratriptan Hydrochloride
Brazil DMF
2020 - August
Valsartan [micronized]
Brazil DMF
2020 - August
Pregabalin
China DMF
2020 - August
Tizanidine
CEP Submitted
2020 - July
Montelukast Sodium Ph.Eur.
Brazil DMF
2020 - July
Gemcitabine Hydrochloride
Brazil DMF
2020 - July
Sertraline HCl (SET4L)
Brazil DMF
2020 - July
Rivaraoxaban
CEP Submitted
2020 - June
Ticagrelor
Brazil DMF
2020 - June
Levetiracetam
Brazil DMF
2020 - June
Clopidogrel Bisulphate Form-1
Brazil DMF
2020 - June
Sugammadex Sodium
Brazil DMF
2020 - June
Sitagliptin HCl (CIP)
Korea DMF
2020 - June
Icatibant Acetate
Europe ASMF filed
2020 - June
Azacitidine
Japan DMF
2020 - June
Liraglutide
USDMF
2020 - May
Valsartan
Canada DMF
2020 - May
Esclicabazepine Acetate
Europe ASMF filed
2020 - May
Abiraterone acetate
Europe ASMF filed
2020 - April
Valsartan [Compacted]
Brazil DMF
2020 - April
Dasatinib SPG Solvate
Brazil DMF
2020 - April
Atorvastatin Calcium Trihydrate (Form-1)
Canada DMF
2021 - December
Moxifloxacin hydrochloride
Brazil DMF
2021 - December
Mirabegron [Alpha]
Brazil DMF
2021 - December
Sitagliptin Phosphate MH
Brazil DMF
2021 - November
Eribulin Mesylate
USDMF
2021 - November
Sacubitril/Valsartan
China DMF
2021 - November
Gemcitabine Hydrochloride
China DMF
2021 - November
Azacitidine
China DMF
2021 - November
Rivaroxaban (Ph.Eur)
Brazil DMF
2021 - November
Lenalidomide [Form-A]
CEP Submitted
2021 - October
Quetiapine Fumarate (Ph.Eur)
Brazil DMF
2021 - October
Quetiapine Fumarate (USP)
Brazil DMF
2021 - October
Rabeprazole Sodium (Form-Y)
Brazil DMF
2021 - October
Pioglitazone Hydrochloride
Japan DMF
2021 - October
Atorvastatin Calcium (Amorphous)
Brazil DMF
2021 - September
Enalaprilat
USDMF
2021 - September
Atorvastatin Calcium [Form-P]
Brazil DMF
2021 - September
Dabigatran Etexilate Mesilate [Form-2]
Brazil DMF
2021 - September
Dutasteride [Form-II]
Brazil DMF
2021 - September
Cinacalcet HCl
China DMF
2021 - September
Mirabegron (Alpha)
China DMF
2021 - August
Ibandronate Sodium Monohydrate [Form-B]
Brazil DMF
2021 - July
Edaravone
CEP Submitted
2021 - July
Ranolazine
CEP Submitted
2021 - July
Enzalutamide
Brazil DMF
2021 - July
Metoprolol Succinate FW
Brazil DMF
2021 - June
Lenvatinib mesylate (Form C)
USDMF
2021 - June
Dapagliflozin PG Solvate [Micronized]
Korea DMF
2021 - June
Clopidogrel Bisulphate [Form-II]
Korea DMF
2021 - June
Olanzapine [Form-I]
Korea DMF
2021 - June
Levofloxacin (USP) Hemihydrate
Korea DMF
2021 - June
Azacitidine
Brazil DMF
2021 - June
Pregabalin
Brazil DMF
2021 - June
Diluted Everolimus
Brazil DMF
2021 - June
Atorvastatin Calcium Trihydrate [Form-I] USP
Brazil DMF
2021 - June
Midostaurin - Crystalline Form II
Brazil DMF
2021 - May
Dimethyl Fumarate
EDMF filed
2021 - May
Olanzapine
Korea DMF
2021 - May
Ropinirole
CEP Submitted
2021 - May
Rivastigmine HT P-1
CEP Submitted
2021 - May
Esomeprazole Magnesium Trihydrate
CEP Submitted
2021 - May
Eribulin Fragment A
USDMF
2021 - April
Pregabalin
USDMF
2021 - March
Lenalidomide (LEU1)
Brazil DMF
2021 - March
Losartan Potassium
Japan DMF
2021 - March
Clopidogrel Bi-sulfate (Form-II)
Japan DMF
2021 - March
Amlodipine Besilate
China DMF
2021 - March
Abiraterone Acetate
Japan DMF
2021 - March
Naproxen Sodium
Brazil DMF
2021 - March
Naproxen
Brazil DMF
2021 - March
Sitagliptin Phosphate Ph.Eur (monohydrate)
CEP Submitted
2021 - March
Apalutamide (Amorphous)
USDMF
2021 - March
Finasteride (Form-I)
China DMF
2021 - March
Ondansetron base
Brazil DMF
2021 - March
Rabeprazole Sodium [Amorphous]
Japan DMF
2021 - March
Dabigatran Etexilate Mesylate
Korea DMF
2021 - March
Bendamustine Hydrochloride
Brazil DMF
2021 - March
Sitagliptin Phosphate Monohydrate USP
Brazil DMF
2021 - March
Rabeprazole Sodium [Amorphous]
China DMF
2021 - March
Pregabalin
China DMF
2021 - March
Fingolimod Hydrochloride
China DMF
2021 - March
Dapagliflozin (Amorphous)
China DMF
2021 - March
Olaparib
USDMF
2021 - March
Diroximel Fumarate
USDMF
2021 - March
Sitagliptin Phosphate Monohydrate USP
USDMF
2021 - March
Lurasidone HCl
Brazil DMF
2021 - March
Atorvastatin Calcium Trihydrate [Form-I] ATN process
China DMF
2021 - March
Rivaroxaban
Korea DMF
2021 - March
Pazopanib Hydrochloride
USDMF
2021 - March
Finasteride (Form-I)
Brazil DMF
2021 - February
Permethrin-25:75
CEP Submitted
2021 - February
Pregabalin
Korea DMF
2021 - February
Ondansetron Hydrochloride
Korea DMF
2021 - February
Sitagliptin Phosphate USP (monohydrate)
USDMF
2021 - February
Hydroxychloroquine Sulfate
USDMF
2021 - February
Favipiravir
USDMF
2021 - February
Levetiracetam
Korea DMF
2021 - February
Clopidogrel Bisulphate Form-2
CEP Submitted
2021 - January
Bendamustine HCl
Canada DMF
2021 - January
Fexofenadine Form-1
CEP Submitted
2021 - January
Mirabegron
Europe ASMF filed
2022 - December
Capecitabine
Japan DMF
2022 - December
Dabigatran Etexilate Mesylate
China DMF
2022 - December
Naproxen
China DMF
2022 - November
Ketorolac Tromethamine
China DMF
2022 - October
Linagliptin
EUDMF
2022 - October
Linagliptin
Brazil DMF
2022 - October
Dimethyl Fumarate
EUDMF
2022 - October
Nilotinib Hydrochloride Monohydrate
Brazil DMF
2022 - October
Levocetirizine Dihydrochloride
Brazil DMF
2022 - October
Clopidogrel Bisulphate (Form - II)
China DMF
2022 - September
Sitagliptin Phosphate Monohydrate
Korea DMF
2022 - September
Sumatriptan Succinate USP
USDMF
2022 - September
Atorvastatin Calcium Trihydrate (Form-1)
Brazil DMF
2022 - September
Dimethyl Fumarate
Brazil DMF
2022 - September
Atorvastatin Calcium Trihydrate (Form-1)
Japan DMF
2022 - September
Clopidogrel Bisulfate [Form-II]
EUDMF
2022 - August
Metoprolol Succinate
CEP Submitted
2022 - August
Clopidogrel Bisulfate [Form-I] CIP
Brazil DMF
2022 - August
Moxifloxacin Hydrochloride USP
Brazil DMF
2022 - August
Fexofenadine Hydrochloride
Korea DMF
2022 - August
Clopidogrel Bisulfate [Form-II]
CEP Submitted
2022 - July
Nilotinib Hydrochloride
USDMF
2022 - July
Tofacitinib Citrate
USDMF
2022 - July
Eribulin Mesylate
Canada DMF
2022 - July
Palbociclib [Form-A]
Brazil DMF
2022 - June
Bempedoic Acid
Brazil DMF
2022 - June
Lurasidone Hydrochloride
EUDMF
2022 - June
Eribulin Mesylate
EUDMF
2022 - May
Ticagrelor
Russia DMF
2022 - May
Escitalopram Oxalate
CEP Submitted
2022 - May
Sugammadex Sodium
Taiwan DMF
2022 - May
Sitagliptin Phosphate Monohydrate
CEP Submitted
2022 - April
Losartan Potassium
Japan DMF
2022 - March
Siponimod Hemifumarate
USDMF
2022 - March
Bempedoic Acid
USDMF
2022 - March
Risperidone [Form-1]
Brazil DMF
2022 - March
Sacubitril + Valsartan Crystalline
Brazil DMF
2022 - March
Ramipril
Brazil DMF
2022 - March
Levofloxacin Hemihydrate
Brazil DMF
2022 - March
Voriconozole
Brazil DMF
2022 - March
Apremilast [Amorphous]
Brazil DMF
2022 - March
Apremilast [Form-B]
Brazil DMF
2022 - March
Siponimod Hemifumarate
Brazil DMF
2022 - March
Metoprolol Succinate
China DMF
2022 - March
Dapagliflozin PG Solvate
China DMF
2022 - March
Pemetrexed Disodium Heptahydrate
China DMF
2022 - March
Clopidogrel Bisulphate [Form-1]
Japan DMF
2022 - March
Rivaroxaban
Japan DMF
2022 - March
Lenalidomide [Form-A]
Japan DMF
2022 - March
Naratriptan Hydrochloride
Japan DMF
2022 - March
Fingolimod Hydrochloride
CEP DMF Filed
2022 - March
Sugammadex Sodium
Canada DMF
2022 - March
Apremilast Form B
Korea DMF
2022 - March
Rabeprazole Sodium [Amorphous]
Korea DMF
2022 - March
Sumatriptan Succinate
Korea DMF
2022 - March
Enzalutamide
Korea DMF
2022 - March
Sacubitril/Valsartan
Korea DMF
2022 - March
Pioglitazone Hydrochloride
Korea DMF
2022 - March
Montelukast Sodium
Korea DMF
2022 - March
Eribulin Mesylate
Australia DMF
2022 - March
Molnupiravir
WHO DMF Filed
2022 - March
Fexofenadine Hydrochloride (Form-I)
Brazil DMF
2022 - February
Omeprazole Magnesium
CEP Submitted
2022 - February
Dasatinib Monohydrate
Japan DMF
2022 - February
Dapagliflozin Amorphous
Brazil DMF
2022 - January
Losartan Potassium [Form-I]
Korea DMF
2022 - January
Losartan Potassium [Form-I]
Brazil DMF
2022 - January
Losartan Potassium [Form 1]
CEP Submitted
2022 - January
Capecitabine
Japan DMF
2023 - December
Cabozantinib (S)-Malate [Form N-2]
USDMF
2023 - December
Cabozantinib Intermediate (CZT3)*
USDMF
2023 - December
Ezetimibe (EZE)
USDMF
2023 - December
Lumateperone Tosylate
Brazil DMF
2023 - December
Roxadustat
Brazil DMF
2023 - December
Pantoprazole sodium sesquihydrate (Form-I) Ph. Eur
Brazil DMF
2023 - December
Rabeprazole sodium Ph. Eur
Brazil DMF
2023 - December
Carfilzomib
Brazil DMF
2023 - December
Lenalidomide Form-A
China DMF
2023 - December
Dabigatran Etexilate Mesylate
CEP Submitted
2023 - December
Mirabegron (Alpha Form)
CEP Submitted
2023 - December
Lenvatinib Form-C
Korea DMF
2023 - December
Capecitabine
Korea DMF
2023 - December
Dasatinib Monohydrate
Korea DMF
2023 - November
Lansoprazole
China DMF
2023 - November
Ferric Carboxy Maltose
Australia DMF
2023 - November
Olaparib
Brazil DMF
2023 - November
Dapagliflozin Amorphous
Russia DMF
2023 - November
Mirabegron
Egypt DMF
2023 - October
Cabazitaxel
Egypt DMF
2023 - October
Sugammadex Sodium
Singapore DMF
2023 - October
Liraglutide
Canada DMF
2023 - October
Varenicline Tartrate
Brazil DMF
2023 - October
Ferric Carboxymaltose
EUDMF
2023 - October
Pantoprazole Sodium
EUDMF
2023 - October
Nilotinib Hydrochloride Monohydrate
Korea DMF
2023 - October
Dapagliflozin (Amorphous)
Israel DMF
2023 - October
Roxadustat Form-A
China DMF
2023 - October
Nilotinib Hydrochloride Monohydrate
Australia DMF
2023 - October
Tafamidis Meglumine
Brazil DMF
2023 - September
Fosaprepitant Dimeglumine
Brazil DMF
2023 - September
Pregabalin
Canada DMF
2023 - September
Apixaban
Australia DMF
2023 - September
Sitagliptin hydrochloride Monohydrate
Saudi Arabia
2023 - September
Azacitidine
Egypt DMF
2023 - September
Linagliptin
Saudi Arabia
2023 - September
Dapagliflozin Amorphous
EUDMF
2023 - September
Omeprazole Magnesium
USDMF
2023 - September
Fexofenadine HCl Form I
Brazil DMF
2023 - August
Varenicline Tartrate
USDMF
2023 - August
Olaparib [Form-A]
China DMF
2023 - July
Linagliptin
Australia DMF
2023 - July
Liraglutide
EUDMF
2023 - July
Gatifloxacin Anhydrous
Brazil DMF
2023 - June
Nilotinib Hydrochloride Monohydrate
CEP Submitted
2023 - June
Tofacitinib Citrate
Brazil DMF
2023 - June
Rabeprazole Sodium
Russia DMF
2023 - June
Linagliptin
Canada DMF
2023 - June
Esomeprazole Magnesium Trihydrate
China DMF
2023 - May
Sugammadex Sodium
Japan DMF
2023 - May
Midostaurin
Australia DMF
2023 - May
Ramipril
Russia DMF
2023 - May
Moxifloxacin Hydrochloride
Singapore DMF
2023 - May
Pantoprazole Sodium Sesquihydrate
CEP Submitted
2023 - April
Ciprofloxacin Hydrochloride
China DMF
2023 - April
Telmisartan
GCC DMF
2023 - April
Bortezomib
Egypt DMF
2023 - March
Fosaprepitant Dimeglumine
USDMF
2023 - March
TBA-7A / Sitagliptin N-Boc Acid
USDMF
2023 - March
Salcaprozate Sodium
USDMF
2023 - March
Cabozantinib Hydrochloride
USDMF
2023 - March
Lumateperone Tosylate
USDMF
2023 - March
Clopidogrel Bisulphate [Form-II] USP DIFA
Brazil DMF
2023 - March
Cetirizine Dihydrochloride USP
Brazil DMF
2023 - March
Fluoxetine Hydrochloride USP
Brazil DMF
2023 - March
Lenvatinib Mesylate (Form C)
Brazil DMF
2023 - March
Pioglitazone Hydrochloride USP
Brazil DMF
2023 - March
Pioglitazone Hydrochloride Ph. Eur
Brazil DMF
2023 - March
Pantoprazole Sodium Sesquihydrate
Brazil DMF
2023 - March
Levofloxacin Hemihydrate Ph.Eur
Brazil DMF
2023 - March
Pemetrexed Disodium (Heptahydrate)
CEP Submitted
2023 - March
Nilotinib Hydrochloride Monohydrate
Canada DMF
2023 - March
Dimethyl Fumarate
China DMF
2023 - March
Montelukast Sodium
China DMF
2023 - March
Voriconazole CIP
China DMF
2023 - March
Nilotinib Hydrochloride
China DMF
2023 - March
Rivastigmine
China DMF
2023 - March
Valsartan
Japan DMF
2023 - March
Abiraterone Acetate
Korea DMF
2023 - March
Naratriptan Hydrochloride
Korea DMF
2023 - March
Enzalutamide
Taiwan DMF
2023 - March
Enzalutamide
Singapore DMF
2023 - February
Esomeprazole Magnesium Trihydrate
CEP Submitted
2023 - February
Atorvastatin Calcium Trihydrate (Form-1) USP
China DMF
2023 - February
Tafamidis Meglumine
USDMF
2023 - February
Pemetrexed Disodium (Heptahydrate)
Korea DMF
2023 - February
Sumatriptan succinate
Brazil DMF
2023 - January
Sumatriptan succinate
CEP Submitted
2023 - January
Abiraterone Acetate
Brazil DMF
2023 - January
Pregabalin
Brazil DMF
2023 - January
Apalutamide Form-B
Brazil DMF
2024 - December
Quetiapine Fumarate
Japan DMF
2024 - December
Cinacalcet Hydrochloride
China DMF
2024 - December
Abemaciclib
Brazil DMF
2024 - December
Dabigatran Etexilate Mesylate (P2)
Brazil DMF
2024 - December
Sitagliptin Phosphate Monohydrate (Product code:SPT-4)
CEP Submitted
2024 - December
Abemaciclib
USDMF
2024 - December
Voclosporin
USDMF
2024 - December
Mavacamten
USDMF
2024 - November
Ketorolac Tromethamine (Parenteral)
Brazil DMF
2024 - November
Moxifloxacin Hydrochloride
Egypt DMF
2024 - November
Ferric Carboxy Maltose
Malaysia DMF
2024 - November
Atorvastatin Calcium Trihydrate (Form-1) (ATO-3 route)
Oman DMF
2024 - November
Siponimod Hemifumarate
Australia DMF
2024 - October
Benztropine Mesylate
Saudi Arabia
2024 - October
Dimethyl Fumarate
Saudi Arabia
2024 - October
Memantine Hydrochloride
Russia DMF
2024 - October
Sitagliptin Phosphate Monohydrate
USDMF
2024 - October
Cabozantinib (S)-Malate [Form N-2]
Brazil DMF
2024 - October
Sacubitril Sodium
Brazil DMF
2024 - October
Ferric Carboxy Maltose
China DMF
2024 - October
Ezetimibe
Brazil DMF
2024 - October
Sitagliptin Phosphate Monohydrate
Brazil DMF
2024 - October
Dasatinib Monohydrate
Brazil DMF
2024 - October
Dabigatran Etexilate Mesylate
USDMF
2024 - October
Empagliflozin [Product code: EGF8]
Canada DMF
2024 - October
Naproxen Sodium Ph. Eur
Brazil DMF
2024 - October
Linagliptin Form (A+B)
EUDMF
2024 - August
Sacubitril/Valsartan
Australia DMF
2024 - August
Dabigatran Etexilate Mesylate
CEP Submitted
2024 - August
Sacubitril Sodium
USDMF
2024 - July
Dasatinib Monohydrate
Australia DMF
2024 - July
Lenvatinib Mesylate Form-C
Australia DMF
2024 - July
Empagliflozin Crystalline [Micronized]
Australia DMF
2024 - June
Lanreotide
US filing
2024 - June
Mirabegron Ph. Eur
Brazil DMF
2024 - June
Dasatinib Monohydrate
Canada DMF
2024 - June
Nilotinib Hydrochloride Monohydrate
Taiwan DMF
2024 - June
Rivastigmine Hydrogen Tartrate
Taiwan DMF
2024 - June
Midostaurin Amorphous
India
2024 - June
Bempedoic Acid
India
2024 - June
Pantoprazole Sodium Sesiquihydrate
Saudi Arabia
2024 - May
Ketorolac Tromethamine
Saudi Arabia
2024 - May
Enzalutamide
Canada DMF
2024 - April
Cabazitaxel
Taiwan DMF
2024 - March
Relugolix
USDMF
2024 - March
Ruxolitinib Phosphate
USDMF
2024 - March
Lenvatinib Mesylate (Form-C)
Canada DMF
2024 - March
Levocetirizine Dihydrochloride
CEP Submitted
2024 - March
Irbesartan
CEP Submitted
2024 - March
Relugolix Sodium
Brazil DMF
2024 - March
Ruxolitinib Phosphate
Brazil DMF
2024 - March
Carfilzomib
China DMF
2024 - March
Decitabine
Korea DMF
2024 - February
Edaravone
Brazil DMF
2024 - February
Ripretinib
USDMF
2024 - February
Ripretinib
Brazil DMF
2024 - February
Vonoprazan Fumarate
USDMF
2024 - February
Vonoprazan Fumarate
Brazil DMF
2024 - February
Ondansetron
Canada DMF
2024 - February
Dabigatran Etexilate Mesylate
Russia DMF
2024 - February
Permethrin BPC cis trans 25 75
Korea DMF
2024 - February
Lomustine
China DMF
2024 - February
Pantoprazole Sodium Sesiquihydrate
China DMF
2024 - February
Donepezil Hydrochloride Monohydrate (Form-1)
CEP Submitted
2024 - January
Lenalidomide Form-A
Japan DMF
2024 - January
Linagliptin Form A+B
Brazil DMF
2025 - December
Atorvastatin Calcium Trihydrate [Form-I]
USA
2025 - December
Nilotinib Premix (HPMC AS)
USA
2025 - December
Abemaciclib
Canada DMF
2025 - December
Sumatriptan Succinate
Japan DMF
2025 - December
Tafamidis Meglumine
Canada DMF
2025 - December
Rivaroxaban (Process-II)
USA
2025 - December
Naratriptan Hydrochloride
Russia DMF
2025 - December
Lomustine
Russia DMF
2025 - December
Fondaparinux Sodium
Saudi Arabia
2025 - December
Fondaparinux Sodium
EU
2025 - November
Linagliptin
UK
2025 - November
Pemetrexed Disodium
Saudi Arabia
2025 - November
Empagliflozin
Saudi Arabia
2025 - November
Carfilzomib
EU
2025 - November
Empagliflozin
Australia DMF
2025 - November
Empagliflozin
Singapore DMF
2025 - November
Dapagliflozin Amorphous
Indonesia
2025 - November
Dapagliflozin Propanediol
Singapore DMF
2025 - October
Tizanidine Hydrochloride
CEP DMF Filed
2025 - October
Naproxen Sodium
Malaysia DMF
2025 - October
Montelukast Sodium
Benin
2025 - October
Empagliflozin
Malaysia DMF
2025 - October
Dasatinib Monohydrate
Saudi Arabia
2025 - October
Carfilzomib
Japan DMF
2025 - October
Tucatinib Hemiethanolate
India
2025 - October
Lurasidone hydrochloride
Taiwan DMF
2025 - September
Deucravacitinib
Brazil DMF
2025 - September
Mirabegron (alpha)
Saudi Arabia
2025 - September
Palbociclib
Australia DMF
2025 - September
Valsartan, Essential Amorphous Form
Europe (CEP)
2025 - September
Erubilin
Saudi Arabia
2025 - September
Azacitidine
Saudi Arabia
2025 - September
Palonosetron Hydrochloride
Brazil DMF
2025 - September
Dapagliflozin Propanediol
Europe (CEP)
2025 - September
Gemcitabine Hydrochloride
Saudi Arabia
2025 - August
Apixaban
Sweden
2025 - August
Apixaban
Singapore DMF
2025 - August
Cetirizine Dihydrochloride
Egypt DMF
2025 - August
Ruxolitinib Hemifumarate
Australia DMF
2025 - August
Edoxaban Tosylate Monohydrate
Brazil DMF
2025 - August
Lenalidomide Povidone Premix
Egypt DMF
2025 - August
Tucatinib Copovidone ASD
USDMF
2025 - August
Gemcitabine Hydrochloride
Saudi Arabia
2025 - July
Permethrin
Saudi Arabia
2025 - July
Liraglutide
Saudi Arabia
2025 - July
Relugolix
India
2025 - July
Voriconazole
Russia DMF
2025 - July
Edoxaban Tosylate
USDMF
2025 - June
Cabazitaxe
Kenya
2025 - June
Docetaxel Anhydrous
Kenya
2025 - June
Palonosetron Hydrochloride USP
Ethiopia
2025 - June
Cabazitaxel
Kenya
2025 - June
Tucatinib Hemiethanolate
Brazil DMF
2025 - May
Ruxolitinib Hemifumarate
Canada DMF
2025 - May
Dapagliflozin Amorphous
Switzerland
2025 - May
Nilotinib Hydrochloride Monohydrate
Indonesia
2025 - April
Bempedoic acid
Russia DMF
2025 - March
Montelukast Sodium
Japan DMF
2025 - March
Ruxolitinib Hemifumarate
Canada DMF
2025 - March
Apixaban
Taiwan DMF
2025 - March
Palbociclib
Canada DMF
2025 - March
Deucravacitinib
USDMF
2025 - March
Finerenone
USDMF
2025 - March
Niraparib Tosylate Monohydrate
USDMF
2025 - March
Tucatinib
USDMF
2025 - March
Voclosporin
Brazil DMF
2025 - March
Lanreotide
Brazil DMF
2025 - March
Pomalidomide
2025 - March
Vonoprazan Fumarate
Korea DMF
2025 - March
Palbociclib
Korea DMF
2025 - March
Ezetimibe (Unmicronized)
Korea DMF
2025 - March
Mavacamten Form-A
Brazil DMF
2025 - March
Fexofenadine HCl (Form-1) -FXA4 process
CEP Submitted
2025 - March
Amlodipine Besylate (TY45)
CEP Submitted
2025 - March
Tucatinib Hemiethanolate
USDMF
2025 - March
Tizanidine Hydrochloride USP (TZN-Process)
USDMF
2025 - March
Enzalutamide Premix (20% w/w)
USDMF
2025 - March
Pazopanib HCl
EUDMF
2025 - March
Atorvastatin Calcium Trihydrate form-1 [ATO-3 process]
CEP Submitted
2025 - March
Ezetimibe (Micronized)
Korea DMF
2025 - February
Montelukast Sodium
Japan DMF
2025 - February
Pioglitazone Hydrochloride
Canada DMF
2025 - February
Cabozantinib S- Maleate (N2 Form)
Korea DMF
2025 - February
Ruxolitinib Hemifumarate
Israel DMF
2025 - February
Palbociclib
Singapore DMF
2025 - February
Ferric Carboxy Maltose
Saudi Arabia
2025 - January
Fexofenadine Form I
Brazil DMF
2025 - January
Sacubitril/ Valsartan
Canada DMF
2025 - January
Dasatinib Monohydrate
Taiwan DMF
2025 - January
Pazopanib
Taiwan DMF